MAIA Biotechnology
MAIA
20 hedge funds and large institutions have $2.75M invested in MAIA Biotechnology in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
18% more funds holding
Funds holding: 17 → 20 (+3)
0.82% less ownership
Funds ownership: 6.14% → 5.32% (-0.82%)
44% less capital inflows, than outflows
Capital inflows: $263K | Capital outflows: $466K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$93.6K |
| 2 |
State Street
Boston,
Massachusetts
|
+$45.2K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$38.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$27.9K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$17.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Halter Ferguson Financial
Carmel,
Indiana
|
-$326K |
| 2 |
Naviter Wealth
Little Rock,
Arkansas
|
-$62.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$46.9K |
| 4 |
XTX Topco
George Town,
Cayman Islands
|
-$30.9K |
| 5 |
Sunbelt Securities
Houston,
Texas
|
-$281 |
MAIA Hedge Fund Activity: Q4 2024 in Review
20 of the 7,623 institutional investors tracked by Wall St. Rank reported a position in MAIA Biotechnology (MAIA) for Q4 2024, worth a combined $2.75M — down 34% from $4.15M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MAIA positions and 4 closed out — a net gain of 3 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $93.6K. The largest seller was Halter Ferguson Financial, cutting an estimated $326K.
- 20 institutional investors held MAIA Biotechnology (MAIA) as of Q4 2024, up from 17 in Q3 2024.
- Funds reported $2.75M of MAIA Biotechnology stock for Q4 2024, down 34% quarter-over-quarter.
- 7 funds opened new MAIA Biotechnology positions in Q4 2024 and 4 closed out, a net change of +3 holders.
- The largest MAIA Biotechnology buyer in Q4 2024 was Jane Street, an estimated $93.6K added.
- The largest MAIA Biotechnology seller in Q4 2024 was Halter Ferguson Financial, an estimated $326K sold.
Based on aggregated 13F filings for Q4 2024.